2021
DOI: 10.1016/j.bbcan.2020.188466
|View full text |Cite
|
Sign up to set email alerts
|

Organoid model: A new hope for pancreatic cancer treatment?

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
21
0

Year Published

2021
2021
2023
2023

Publication Types

Select...
9
1

Relationship

0
10

Authors

Journals

citations
Cited by 39 publications
(21 citation statements)
references
References 76 publications
0
21
0
Order By: Relevance
“…Pancreatic cancer (PC) is responsible for the fourth highest number of tumor-related deaths worldwide [ 1 ]. Although therapeutic options for patients with PC have improved, the 5-year survival rate for patients with PC is still <5% [ 2 , 3 ]. The poor prognosis for patients with PC is caused by the high proliferation and early invasion of cancer cells.…”
Section: Introductionmentioning
confidence: 99%
“…Pancreatic cancer (PC) is responsible for the fourth highest number of tumor-related deaths worldwide [ 1 ]. Although therapeutic options for patients with PC have improved, the 5-year survival rate for patients with PC is still <5% [ 2 , 3 ]. The poor prognosis for patients with PC is caused by the high proliferation and early invasion of cancer cells.…”
Section: Introductionmentioning
confidence: 99%
“…For the latter, the existing methods on the construction of organoids are challenging to standardize since organic-like material needs to be cultivated in droplets of solidified substrates indispensably. The local differences in physical parameters and accessibility of growth factors result in variations in the shape, size, and distribution of organoids [ 20 ]. So, it is challenging to develop a reliable and stable system to decipher the tumor environment.…”
Section: Introductionmentioning
confidence: 99%
“…Compared with favorable prognosis tumors, PC is characterized by its high degree of malignancy, insidious onset, no typical symptoms, many anatomical sites, low resection rate, high recurrence rate and poor prognosis. PC patients have an average 5-year survival rate of less than 10%, and less than 3% for patients with advanced or metastatic disease (Chen et al 2021). The incidence of PC continues to increase and there is an urgent need to improve survival rates.…”
Section: Introductionmentioning
confidence: 99%